BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ueda H, Akiyama Y, Shimada S, Mogushi K, Serizawa M, Matsumura S, Mitsunori Y, Aihara A, Ban D, Ochiai T, Kudo A, Tanabe M, Tanaka S. Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs. Endocr Relat Cancer 2018;25:619-31. [PMID: 29599123 DOI: 10.1530/ERC-17-0328] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gulve N, Su C, Deng Z, Soldan SS, Vladimirova O, Wickramasinghe J, Zheng H, Kossenkov AV, Lieberman PM. DAXX-ATRX regulation of p53 chromatin binding and DNA damage response. Nat Commun 2022;13:5033. [PMID: 36028493 DOI: 10.1038/s41467-022-32680-8] [Reference Citation Analysis]
2 Wen T, Chen QY. Dynamic Activity of Histone H3-Specific Chaperone Complexes in Oncogenesis. Front Oncol 2021;11:806974. [PMID: 35087762 DOI: 10.3389/fonc.2021.806974] [Reference Citation Analysis]
3 Borri F, Bonfiglio R, Mandarano M. Pathology of Pancreatic Neuroendocrine Tumors. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_37] [Reference Citation Analysis]
4 Borri F, Bonfiglio R, Mandarano M. Pathology of Pancreatic Neuroendocrine Tumors. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_37-1] [Reference Citation Analysis]
5 Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029-1050. [PMID: 31738624 DOI: 10.1080/14737140.2019.1693893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
6 Cheng X, Jiang Q, Hu X, Huang X, Hui L, Wei Y, Li N, Wang N, Shen J, Zhang Y, Lei L. The loss of ATRX/DAXX complex disturbs rDNA heterochromatinization and promotes development of glioma.. [DOI: 10.1101/745307] [Reference Citation Analysis]
7 Shi Y, Jin J, Wang X, Ji W, Guan X. DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors. Neoplasia 2019;21:533-44. [PMID: 31029033 DOI: 10.1016/j.neo.2019.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]